The 'artificial pancreas', which has been developed by the University of Virginia School of Medicine, is to enter its final testing phase.
The announcement was made in a press release issued on January 4. The 'artificial pancreas' would allow type one diabetics to automatically monitor and manage their blood sugar levels; two clinical trials are due to get underway in early 2016.
Studies are to be conducted in nine locations throughout the United States and Europe. If successful, the management system could ultimately one day lead to regulatory authorities approving the 'artificial pancreas' for the treatment of type one diabetes.
240 patients will take part in the first study, while 180 will participate in the second trial.
Lead researcher of the first study, Boris Kovatchev, PhD, director of the UVA Center for Diabetes Technology, said:
“To be ultimately successful as an optimal treatment for diabetes, the artificial pancreas needs to prove its safety and efficacy in long-term pivotal trials in the patient's natural environment.”
“Our foremost goal is to establish a new diabetes treatment paradigm: the artificial pancreas is not a single-function device; it is an adaptable, wearable network surrounding the patient in a digital treatment ecosystem."
What is the artificial pancreas?
If it proves successful, the artificial pancreas could eliminate the need for finger prick blood tests and the manual injection of insulin.
Source:
http://www.newswise.com/articles/pioneering-artificial-pancreas-to-undergo-final-tests
The announcement was made in a press release issued on January 4. The 'artificial pancreas' would allow type one diabetics to automatically monitor and manage their blood sugar levels; two clinical trials are due to get underway in early 2016.
Studies are to be conducted in nine locations throughout the United States and Europe. If successful, the management system could ultimately one day lead to regulatory authorities approving the 'artificial pancreas' for the treatment of type one diabetes.
240 patients will take part in the first study, while 180 will participate in the second trial.
Lead researcher of the first study, Boris Kovatchev, PhD, director of the UVA Center for Diabetes Technology, said:
“To be ultimately successful as an optimal treatment for diabetes, the artificial pancreas needs to prove its safety and efficacy in long-term pivotal trials in the patient's natural environment.”
“Our foremost goal is to establish a new diabetes treatment paradigm: the artificial pancreas is not a single-function device; it is an adaptable, wearable network surrounding the patient in a digital treatment ecosystem."
What is the artificial pancreas?
If it proves successful, the artificial pancreas could eliminate the need for finger prick blood tests and the manual injection of insulin.
Source:
http://www.newswise.com/articles/pioneering-artificial-pancreas-to-undergo-final-tests
